首页> 外文期刊>Analytical chemistry >Amplification and Preparation of Cellular O-Glycomes for Functional Glycomics
【24h】

Amplification and Preparation of Cellular O-Glycomes for Functional Glycomics

机译:功能性含量的细胞O-聚合物的扩增和制备

获取原文
获取原文并翻译 | 示例
       

摘要

Mucin-type O-glycans play key roles in many cellular processes, and they are often altered in human diseases. A major challenge in studying the role of O-glycans through functional O-glycomics is the absence of a complete repertoire of the glycans that comprise the human O-glycome. Here we describe a cellular O-glycome preparation strategy, Preparative Cellular O-Glycome Reporter/Amplification (pCORA), that introduces 4-N3-Bn-GalNAc(Ac)(3) as a novel precursor in large-scale cell cultures to generate usable amounts of O-glycans as a potential O-glycome factory. Cultured human non-small cell lung cancer (NSCLC) A549 cells take up the precursor, which is extended by cellular glycosyltransferases to produce 4-N-3-Bn-alpha-O-glycans that are secreted into the culture medium. The O-glycan derivatives can be clicked with a fluorescent bifunctional tag that allows multidimensional HPLC purification and production of a tagged glycan library, representing the O-glycome of the corresponding cells. We obtained similar to 5% conversion of precursor to O-glycans and purified a tagged O-glycan library of over 100 O-glycan derivatives, many of which were present in >100 nmol amounts and were sequenced by sequential MS fragmentation (MSn). These O-glycans were successfully printed onto epoxy glass slides as an O-glycome shotgun microarray. We used this novel array to explore binding activity of serum IgM in healthy persons and NSCLC patients at different cancer stages. This novel strategy provides access to complex O-glycans in significant quantities and may offer a new route to discovery of potential diagnostic disease biomarkers.
机译:粘蛋白型O-Glycans在许多细胞过程中发挥关键作用,并且它们通常在人类疾病中改变。研究O-聚糖通过功能o-族的作用的主要挑战是没有包含人o-glyce的聚糖的完全曲目。在这里,我们描述了一种细胞O- Glycome制备策略,制备细胞O- Glycous报告总和/扩增(PCORA),其引入了4-N3-BN-Galnac(AC)(3)作为在大规模细胞培养物中产生的新型前体可用量的O-Glycans作为潜在的O-Glycome工厂。培养的人非小细胞肺癌(NSCLC)A549细胞占用前体,其被细胞糖基三糖基酶延伸以产生分泌到培养基中的4-N-3-BN-α-o-聚糖。可以用荧光双功能标签点击O-聚糖衍生物,其允许多维HPLC纯化和制备标记的聚糖库,其代表相应细胞的O-GLYCOME。我们获得类似于O-聚糖的前体转化的5%,并纯化了100多种O-聚糖衍生物的标记的O-聚糖病毒,其中许多含量为> 100nmol量,通过顺序MS碎片(MSN)测序。将这些O-聚糖成功地印在环氧玻璃载体上,作为O-Glycome霰弹枪微阵列。我们使用这种新颖的阵列来探讨不同癌症阶段健康人和NSCLC患者的血清IgM的结合活动。这种新的策略提供了对大量的复杂O-Glycans的访问,并且可以提供潜在的诊断疾病生物标志物的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号